Reviewed Mar 2026 | PubMed sources
Active Market
Spain is selected. The evidence comparison is still valid, but provider availability, legal positioning, and cost assumptions may still be staged for later rollout.

Selank vs Semax: Head-to-Head Comparison

Selank and Semax are both Russian-developed regulatory peptides approved in Russia for clinical use. Selank is an anxiolytic based on tuftsin (an immune peptide), while Semax is a nootropic based on ACTH(4-10). Selank targets anxiety and stress; Semax targets cognition and neuroprotection.

Side-by-Side Comparison

DimensionSelankSemax
Evidence LevelApproved in Russia; multiple Russian clinical studiesApproved in Russia; extensive Russian clinical and preclinical data
FDA StatusNot approved in US/EUNot approved in US/EU
MechanismGABA modulation, serotonin metabolism, immune modulation (tuftsin analog)BDNF upregulation, dopamine/serotonin modulation (ACTH fragment)
Primary UseAnxiety, stress, immune supportCognitive enhancement, stroke recovery, neuroprotection
Side EffectsVery well-tolerated; mild fatigue possibleWell-tolerated; mild irritation with nasal use
Route of AdministrationIntranasal dropsIntranasal drops
OnsetAnxiolytic effects within minutes to hoursCognitive effects noticeable within hours
Evidence Level
Selank
Approved in Russia; multiple Russian clinical studies
Semax
Approved in Russia; extensive Russian clinical and preclinical data
FDA Status
Selank
Not approved in US/EU
Semax
Not approved in US/EU
Mechanism
Selank
GABA modulation, serotonin metabolism, immune modulation (tuftsin analog)
Semax
BDNF upregulation, dopamine/serotonin modulation (ACTH fragment)
Primary Use
Selank
Anxiety, stress, immune support
Semax
Cognitive enhancement, stroke recovery, neuroprotection
Side Effects
Selank
Very well-tolerated; mild fatigue possible
Semax
Well-tolerated; mild irritation with nasal use
Route of Administration
Selank
Intranasal drops
Semax
Intranasal drops
Onset
Selank
Anxiolytic effects within minutes to hours
Semax
Cognitive effects noticeable within hours

Peptide Overviews

Selank

BHuman Studies

Selank is a synthetic peptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is approved in Russia as an anxiolytic and nootropic medication.

Sleep & StressNot Approved
View full Selank profile →

Semax

BHuman Studies

Semax is a synthetic peptide derived from the ACTH(4-10) fragment, developed in Russia as a nootropic and neuroprotective agent. It is approved in Russia for stroke, cognitive disorders, and optic nerve disease.

Cognitive EnhancementNot Approved
View full Semax profile →

Supplies for Both

Common research handling and preparation supplies for injectable peptide workflows.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Selank vs Semax: FAQ